A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. 2021

Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College, Biosafety Level 3 Laboratory, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.

The global spread of SARS-CoV-2 is posing major public health challenges. One feature of SARS-CoV-2 spike protein is the insertion of multi-basic residues at the S1/S2 subunit cleavage site. Here, we find that the virus with intact spike (Sfull) preferentially enters cells via fusion at the plasma membrane, whereas a clone (Sdel) with deletion disrupting the multi-basic S1/S2 site utilizes an endosomal entry pathway. Using Sdel as model, we perform a genome-wide CRISPR screen and identify several endosomal entry-specific regulators. Experimental validation of hits from the CRISPR screen shows that host factors regulating the surface expression of angiotensin-converting enzyme 2 (ACE2) affect entry of Sfull virus. Animal-to-animal transmission with the Sdel virus is reduced compared to Sfull in the hamster model. These findings highlight the critical role of the S1/S2 boundary of SARS-CoV-2 spike protein in modulating virus entry and transmission and provide insights into entry of coronaviruses.

UI MeSH Term Description Entries
D008647 Mesocricetus A genus in the order Rodentia and family Cricetidae. One species, Mesocricetus auratus or golden hamster is widely used in biomedical research. Hamsters, Golden,Hamsters, Golden Syrian,Hamsters, Syrian,Mesocricetus auratus,Syrian Golden Hamster,Syrian Hamster,Golden Hamster,Golden Hamster, Syrian,Golden Hamsters,Golden Syrian Hamsters,Hamster, Golden,Hamster, Syrian,Hamster, Syrian Golden,Syrian Hamsters
D011992 Endosomes Cytoplasmic vesicles formed when COATED VESICLES shed their CLATHRIN coat. Endosomes internalize macromolecules bound by receptors on the cell surface. Receptosomes,Endosome,Receptosome
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072283 A549 Cells An immortalized cell line derived from human ADENOCARCINOMA, ALVEOLAR basal epithelial cells isolated from the lungs of a male patient in 1972. The cell line is positive for KERATIN, can synthesize LECITHIN, and contains high levels of POLYUNSATURATED FATTY ACIDS in its PLASMA MEMBRANE. It is used as a model for PULMONARY ALVEOLI function and virus infections, as a TRANSFECTION host, and for PRECLINICAL DRUG EVALUATION. A549 Cell Line,A549 Cell,A549 Cell Lines,Cell Line, A549,Cell Lines, A549,Cell, A549,Cells, A549
D000085962 Angiotensin-Converting Enzyme 2 A transmembrane glycoprotein with an extracellular catalytic domain which functions as a carboxypeptidase. It cleaves a single C-terminal residue from a distinct range of substrates. The catalytic efficiency is 400-fold higher with ANGIOTENSIN II as a substrate than with ANGIOTENSIN I. Angiotensin-converting enzyme 2 is also is a functional receptor for the spike glycoprotein (SPIKE PROTEIN, CORONAVIRUS) of the CORONAVIRUSES SARS-COV, SARS-COV2, and HCOV-NL63. ACE-Related Carboxypeptidase,ACE2 Angiotensin-Converting Enzyme Protein 2,ACE2 Enzyme,ACE2 Protein,Angiotensin Converting Enzyme 2,Angiotensin-Converting Enzyme-Related Carboxypeptidase,ACE Related Carboxypeptidase,ACE2 Angiotensin Converting Enzyme Protein 2,Angiotensin Converting Enzyme Related Carboxypeptidase,Carboxypeptidase, ACE-Related,Carboxypeptidase, Angiotensin-Converting Enzyme-Related
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19

Related Publications

Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
June 2020, bioRxiv : the preprint server for biology,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
April 2022, Science China. Life sciences,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
April 2021, Nature genetics,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
January 2016, PloS one,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
January 2021, Cell,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
January 2020, Nature communications,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
January 2019, Frontiers in cellular and infection microbiology,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
February 2017, Nature genetics,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
April 2018, Cell reports,
Yunkai Zhu, and Fei Feng, and Gaowei Hu, and Yuyan Wang, and Yin Yu, and Yuanfei Zhu, and Wei Xu, and Xia Cai, and Zhiping Sun, and Wendong Han, and Rong Ye, and Di Qu, and Qiang Ding, and Xinxin Huang, and Hongjun Chen, and Wei Xu, and Youhua Xie, and Qiliang Cai, and Zhenghong Yuan, and Rong Zhang
August 2022, Nature genetics,
Copied contents to your clipboard!